[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila
C
C
Servicio de Gastroenterología, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid.
Boixeda de Miquel
D
D
Moreira Vicente
V
V
García Plaza
A
A
D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000188:drug therapy; D004935:Esophageal Diseases / Q000188:drug therapy*; D004941:Esophagitis / Q000188:drug therapy; D005756:Gastritis / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013276:Stomach Ulcer / Q000188:drug therapy; D013312:Stress, Physiological; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
D000897:Anti-Ulcer Agents; D009853:Omeprazole